Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

About 1 in 8 U.S. adults have taken Ozempic or similar medications used to treat Type 2 diabetes and obesity. While these ...

Obesity has been declared a disease by WHO. It is associated not only with heart disease, diabetes, stroke, gallstones, ...

Ozempic and Wegovy are both weekly injections with semaglutide. While the former is approved to treat Type 2 diabetes, the ...

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...

As a new study finds that people who stopped taking semaglutide, the active ingredient in the new blockbuster weight loss ...

Novo Nordisk, which manufactures weight-loss drug Wegovy and ... Munk Knudsen had said last week that reports had linked at ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

The type 2 diabetes medication Ozempic has been hugely popular when prescribed off-label for weight loss, thanks to its ...